Developer docs
API playgroundTry for free, no card

Search company profiles

Ephicacy

Full company profile

uuid0006gc1

Namestring
Ephicacy
Legal namestring
Ephicacy Corporation Limited
Websiteurl
ephicacy.com
Company typeenum
Private
Founded yearint
2005
Descriptiontext

Ephicacy is a privately held clinical biometrics Contract Research Organization (CRO) founded in 2005 in Iselin, NJ, by Ganesh Gopal. The company delivers end-to-end clinical data analytics services to pharmaceutical, biotechnology, and medical device companies across all phases of clinical trials, with stated experience spanning 100+ indications and 1,230+ projects. Its service portfolio is organized around three partnership models — Functional Service Provider (FSP), Project-Based Services, and Consulting — and covers data management, biostatistics, statistical programming (SAS and R), CDISC standards implementation, real-world evidence analytics, pharmacovigilance, medical device biometrics, and an emerging AI for Clinical Data Operations service line. Technology experience includes Spotfire, Tableau, Qlik, R Shiny, SAS, Python, AWS, Sycamore CDR/SCE, Databricks, and standards governance tooling such as Pinnacle21.

The company operates a hybrid onshore-offshore delivery model with offices in the United States, Canada, India (15+ years of operations as a Center of Excellence), and the United Kingdom, enabling 24/7 coverage and cost-effective scaling. Ephicacy holds CDISC Gold Member status, ISO 9001:2015, ISO/IEC 27001:2022, and ISO 22301:2019 certifications, and reports a 94% team retention rate among its 500+ in-house experts, supported by a 3,000+ programmer candidate database. Named enterprise clients include Merck, Bristol Myers Squibb, Pfizer, GSK, Novartis, and Eli Lilly.

Since 2022, Ephicacy has been backed by Great Point Partners, a healthcare-focused private equity firm, and in May 2024 acquired Advance Research Associates to expand biometrics and analytics capabilities. The company underwent a leadership transition in February 2025 with the appointment of Tara Gladwell (formerly President of Rho) as CEO while founder Ganesh Gopal moved to Chairman and President, followed by additional senior leadership additions including Board Director Névine Zariffa (June 2025), SVP of Biometrics Jamie Powers, and Head of India Operations Tyagrajan Swaminathan (March 2026).

Short descriptiontext

Ephicacy is a clinical biometrics CRO serving pharmaceutical, biotech, and medical device companies with data management, biostatistics, statistical programming, CDISC compliance, real-world evidence, and AI-enabled clinical data operations delivered globally across FSP, project-based, and consulting models.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersIselin, United States
HQ citystring
Iselin
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical biometrics services, statistical programming, clinical data management, biostatistics consulting, real-world evidence analytics
Industry5 codes
PRIMARYHLAGAAAF
Clinical Data Management, Biostatistics & Statistical Programming CROs
SECONDARYHLAGAOAB
Data Management, Biostatistics & Statistical Programming FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
SECONDARYHLAGAAAK
Real-World Evidence (RWE), HEOR & Epidemiology CROs
SECONDARYHLAGAAAH
Pharmacovigilance, Risk Management & Medical Affairs CROs
SECONDARYHLAGAAAL
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)
NAICS code2 codes
  • Scientific Research and Development Services5417
  • Research and Development in the Physical, Engineering, and Life Sciences54171
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Clinical Biometrics Contract Research Organization (CRO)
Social media profiles2 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1Functional Service Provider (FSP) Model
TypeManaged Services
Description

Ongoing embedded support where Ephicacy provides dedicated resources that integrate into sponsor teams and operate under sponsor systems and SOPs. Offers scalability with ability to ramp resources up or down while maintaining oversight.

ephicacy.com
2Project-Based Services
TypeProfessional Services
Description

Ephicacy takes full ownership of defined deliverables and timelines with dedicated teams for data managers, programmers, and statisticians. Milestone-based support with budget predictability.

ephicacy.com
3Clinical Development Consulting
TypeProfessional Services
Description

Expert guidance at early planning stages including study design, regulatory interactions, and statistical modeling. Flexible hours and resource-on-demand model.

ephicacy.com
4Hybrid Models
TypeManaged Services
Description

Blending FSP and project-based models to provide support exactly where and how clients need it, accommodating multiple projects with varying support needs.

prweb.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Pricing details3 tiers
1FSP Model - Ongoing embedded support with scalable resources
ModelOtherBilling cadenceMulti-year contract
Notes

Custom pricing based on resource scope, duration, and therapeutic area requirements. Clients pay for the clinical biometrics solutions needed with ability to scale up or down as trial demands shift.

ephicacy.com
2Project-Based Model - Milestone-based delivery with defined deliverables
ModelOutcome Based/ PerformanceBilling cadenceMulti-year contract
Notes

Budgets and timelines established up front and tied to clearly defined deliverables. Accountability for hitting agreed milestones sits with delivery team.

ephicacy.com
3Consulting Model - Expert guidance on demand
ModelOtherBilling cadencePay-as-you-go
Notes

Flexible hours with resource-on-demand model. Early engagement provides extensive time and cost savings through expert modeling.

ephicacy.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Ephicacy is a niche Contract Research Organization (CRO) providing consulting and operational services in statistical programming, SDTM, ADaM, and clinical data management across all phases of clinical trials. It delivers biometrics, biostatistics, CDISC compliance, real-world evidence, pharmacovigilance, and AI-enabled clinical data operations to pharmaceutical, biotech, and medical device sponsors through FSP, project-based, and consulting engagement models.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 94% team retention rate ensuring client programs work with experienced professionals who know their programs
+5 more records
Product overview1 text field

Ephicacy is a biometrics Contract Research Organization (CRO) offering a comprehensive suite of clinical data analytics services organized around three partnership models: Functional Service Provider (FSP), Project-Based Services, and Consulting. The core service portfolio includes Data Management (with sub-services Clinical Programming and Data Integration & Visualization), Biostatistics (with DMC Services), Statistical Programming (with CDISC Standards & Governance and R Programming sub-services), AI for Clinical Data Operations, Real-World Evidence & Observational Study Analytics, Pharmacovigilance (with Clinical Literature Review), Project Management, and Medical Device biometrics support. This is a services-based offering rather than a packaged software product, delivered through a global team across North America, India, and Europe with 24/7 coverage capabilities.

Product and service11 records
1Data Management
CategoryClinical Data Management
Description

Comprehensive clinical trial data management services combining capacity and expertise through a global team with 24/7 coverage, including CRF design, EDC implementation, database design, data cleaning, query management, and medical coding. Includes Clinical Programming and Data Integration & Visualization sub-capabilities such as edit check reports, patient profiles, narratives, and lab reconciliation reports across EDC, labs, imaging, Spotfire, Tableau, Qlik, R Shiny, AWS, and Databricks platforms. Intended for pharmaceutical, biotech, and medical device sponsors running clinical trials.

2Biostatistics
CategoryBiostatistics Services
Description

Real-world and clinical biostatistics services including statistical design, conduct, monitoring, and reporting, plus protocol input, sample size calculations, SAP development, Tables/Listings/Figures (TLFs), CSR development, publications, and Data Monitoring Committee (DMC) support. Includes dedicated DMC services with unblinded output generation across oncology, neuroscience, cardiovascular, and other therapeutic areas. Intended for pharmaceutical and biotech sponsors.

3Statistical Programming
CategoryStatistical Programming
Description

End-to-end statistical programming support including CDISC-compliant SDTM and ADaM dataset programming, TLF production, submission-ready SAS and R programming, ISS/ISE programming, and eSUB package preparation for regulatory submissions. Includes CDISC Standards & Governance (CDASH/SDTM/ADaM mapping, Pinnacle21 validation, eCTD submission packages, define.xml generation) and R Programming (R Shiny dashboards, custom packages, SAS-to-R migration, validated production environments). Programmers average 5+ years of CDISC experience. Intended for clinical trial sponsors requiring regulatory submission-ready datasets.

4AI for Clinical Data Operations
CategoryAI-Enabled Clinical Analytics
Description

AI adoption strategy and tools for clinical data operations including TLF (Tables, Listings, Figures) automation, CSR drafting accelerators, SAS-to-R code migration assistance, data review assistant for anomaly surfacing, clinical literature review copilots, and protocol-to-SAP mappers. Includes governance and validation playbooks and AI training programs. Teams adopting these tools have realized cost reductions up to 30% and target less than 1% error rates in automated steps under defined controls. Intended for clinical development teams seeking efficiency gains in regulated biometrics workflows.

5Real-World Evidence & Observational Study Analytics
CategoryReal-World Evidence Analytics
Description

Real-world evidence analytics services including evidence strategy, data source acquisition from claims/EHR/pharmacy/registries/labs/PRO, data standardization to OMOP, HL7 FHIR, and CDISC, comparative effectiveness analysis, external control arms, treatment pattern analytics, and visualization for submissions. Source-agnostic data strategy intended for pharmaceutical and biotech sponsors pursuing regulatory submissions with real-world data.

6Pharmacovigilance
CategoryPharmacovigilance and Drug Safety
Description

Pharmacovigilance services for detecting, analyzing, and reporting safety signals including safety data analytics, clinical literature review with weekly multilingual monitoring and AI-enabled screening (37,900+ articles screened), signal detection, and regulatory document support (Investigator Brochure, Risk Management Plan, PBRER), plus gap analysis. Intended for pharmaceutical sponsors requiring ongoing drug safety monitoring.

7Project Management
CategoryProject Management
Description

Strategic project management for clinical data operations delivered as a consulting service or as part of FSP and project-based delivery models, providing coordination across technical, operational, and financial dimensions. Intended for clinical trial sponsors requiring outsourced program leadership.

8Medical Device Biometrics
CategoryMedical Device Biometrics
Description

Specialized biometrics support for medical device, diagnostic, and combination-product trials including clinical trial design, IDE strategy, clinical event adjudication, DMC support, database design for dense data capture, complex randomization, and FDA engagement support. Includes 300+ device programs supported and 100+ successful regulatory submissions for medical device programs. Intended for medical device and diagnostic companies.

9Functional Service Provider (FSP) Partnership Model
CategoryPartnership Model
Description

Flexible FSP engagement model offering dedicated functional expertise, scalable resourcing, sponsor-aligned delivery under sponsor processes, SOPs, and systems, and continuity for long-term partnership. Ring-fenced resources embedded within sponsor teams with ability to ramp up or down. Multi-year contract pricing. Intended for enterprise pharma sponsors with ongoing biometrics resourcing needs.

10Project-Based Services Partnership Model
CategoryPartnership Model
Description

Project-based service model with end-to-end delivery ownership where Ephicacy takes full accountability for defined deliverables, timelines, and outcomes with milestone-based support and established budgets. Rapid onboarding and hands-on custom solutions. Multi-year contract pricing. Intended for midsize pharma, biotech, and medical device sponsors with project-scoped biometrics needs.

11Clinical Development Consulting
CategoryPartnership Model
Description

Clinical development consulting providing early-stage strategic guidance including study design optimization, regulatory authority interaction guidance, statistical modeling, standardized data flows, and CDISC compliance implementation. Flexible hours and resource-on-demand model with pay-as-you-go billing. Intended for emerging biotech and small pharma with limited internal biometrics resources.

Scale indicator12 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierMajorTypeOthersAnnounced on2024-05-02
Description

Ephicacy Consulting Group completed the acquisition of Advance Research Associates in May 2024, expanding its biometrics and analytics capabilities.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Fortrea is a global CRO spun out of LabCorp in 2023 offering clinical and biometrics services. Broad incumbent with biometrics overlap; competes against Ephicacy on FSP and biometrics outsourcing bids.

TypeBroad incumbent
Description

IQVIA is the largest global full-service CRO with deep biometrics and RWE capabilities through its Quintiles heritage. Ephicacy's Jamie Powers previously worked at IQVIA. Broader incumbent offering overlapping biometrics but as part of a much wider portfolio.

TypeBroad incumbent
Description

Parexel is a major global full-service CRO with biometrics and biostatistics capabilities. Broad incumbent overlapping with Ephicacy in CDISC, statistical programming and biostatistics but as part of an end-to-end clinical offering.

TypeBroad incumbent
Description

ICON plc is a top-tier global CRO with full clinical and biometrics services following the PRA Health Sciences merger. Broad incumbent competing with Ephicacy on biometrics within larger full-service deals, especially with large pharma.

TypeDirect peer
Description

Cytel is a specialty biometrics CRO with deep biostatistics and statistical programming capabilities serving global pharma and biotech. Directly comparable in services (statistical programming, CDISC, biostatistics) and therapeutic-area focus, with overlapping FSP and consulting delivery models.

TypeDirect peer
Description

Phastar is a specialist biometrics CRO offering data management, biostatistics, statistical programming and CDISC services to pharma and biotech globally. Direct peer in niche biometrics with global delivery model and similar mid-market positioning to Ephicacy.

TypeEmerging player
Description

Precision for Medicine is a CRO specializing in biomarker-driven and precision medicine trials, with biometrics and biostatistics capabilities. Emerging peer with strong overlap in specialty/biomarker-enabled clinical analytics and RWE work relevant to Ephicacy's RWE and specialty therapeutic services.

TypeEmerging player
Description

Clario is a clinical trial technology and endpoint services company with biometrics integration and eCOA/ePRO strengths. Partially overlapping with Ephicacy's data management and clinical data integration services, particularly around EDC, clinical data review and AI-enabled workflows.

TypeDirect peer
Description

Veramed is a biometrics CRO specializing in biostatistics and statistical programming for pharma and biotech. Direct comparable with similar service portfolio, mid-tier customer mix, and biostatistics/statistical programming as primary offerings.

10Rho
TypeDirect peer
Description

Rho is a US-based biometrics-focused CRO offering data management, biostatistics, statistical programming and regulatory services to pharma and biotech. Highly comparable: Ephicacy's new CEO Tara Gladwell came directly from Rho as President, and the two firms compete head-to-head in mid-market biometrics outsourcing.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability12 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles12 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Ephicacy

Clinical Biometrics Contract Research Organization (CRO)ephicacy.com

Ephicacy is a clinical biometrics CRO serving pharmaceutical, biotech, and medical device companies with data management, biostatistics, statistical programming, CDISC compliance, real-world evidence, and AI-enabled clinical data operations delivered globally across FSP, project-based, and consulting models.

What Ephicacy does

Ephicacy is a privately held clinical biometrics Contract Research Organization (CRO) founded in 2005 in Iselin, NJ, by Ganesh Gopal. The company delivers end-to-end clinical data analytics services to pharmaceutical, biotechnology, and medical device companies across all phases of clinical trials, with stated experience spanning 100+ indications and 1,230+ projects. Its service portfolio is organized around three partnership models — Functional Service Provider (FSP), Project-Based Services, and Consulting — and covers data management, biostatistics, statistical programming (SAS and R), CDISC standards implementation, real-world evidence analytics, pharmacovigilance, medical device biometrics, and an emerging AI for Clinical Data Operations service line. Technology experience includes Spotfire, Tableau, Qlik, R Shiny, SAS, Python, AWS, Sycamore CDR/SCE, Databricks, and standards governance tooling such as Pinnacle21.

The company operates a hybrid onshore-offshore delivery model with offices in the United States, Canada, India (15+ years of operations as a Center of Excellence), and the United Kingdom, enabling 24/7 coverage and cost-effective scaling. Ephicacy holds CDISC Gold Member status, ISO 9001:2015, ISO/IEC 27001:2022, and ISO 22301:2019 certifications, and reports a 94% team retention rate among its 500+ in-house experts, supported by a 3,000+ programmer candidate database. Named enterprise clients include Merck, Bristol Myers Squibb, Pfizer, GSK, Novartis, and Eli Lilly.

Since 2022, Ephicacy has been backed by Great Point Partners, a healthcare-focused private equity firm, and in May 2024 acquired Advance Research Associates to expand biometrics and analytics capabilities. The company underwent a leadership transition in February 2025 with the appointment of Tara Gladwell (formerly President of Rho) as CEO while founder Ganesh Gopal moved to Chairman and President, followed by additional senior leadership additions including Board Director Névine Zariffa (June 2025), SVP of Biometrics Jamie Powers, and Head of India Operations Tyagrajan Swaminathan (March 2026).

Ephicacy firmographics

Firmographics
Name
Ephicacy
Legal name
Ephicacy Corporation Limited
Website
https://ephicacy.com
Company type
Private
Founded year
2005
Operating status
Operating
Headcount range
251–500 employees
Short description
Ephicacy is a clinical biometrics CRO serving pharmaceutical, biotech, and medical device companies with data management, biostatistics, statistical programming, CDISC compliance, real-world evidence, and AI-enabled clinical data operations delivered globally across FSP, project-based, and consulting models.
Ownership category
akta.pro rank

Ephicacy industry classification

Industry
Product category
Clinical Biometrics Contract Research Organization (CRO)
NAICS
Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAAAF
Clinical Data Management, Biostatistics & Statistical Programming CROs
SECONDARYHLAGAOAB
Data Management, Biostatistics & Statistical Programming FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
SECONDARYHLAGAAAK
Real-World Evidence (RWE), HEOR & Epidemiology CROs
SECONDARYHLAGAAAH
Pharmacovigilance, Risk Management & Medical Affairs CROs
SECONDARYHLAGAAAL
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)

Keywords

  • Clinical biometrics services
  • Statistical programming
  • Clinical data management
  • Biostatistics consulting
  • Real-world evidence analytics

Where Ephicacy is headquartered

Location

Headquarters

HQ city
Iselin
HQ country
United States
HQ region
North America

Offices3 records

Markets served

Ephicacy business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Functional Service Provider (FSP) Model: Ongoing embedded support where Ephicacy provides dedicated resources that integrate into sponsor teams and operate under sponsor systems and SOPs. Offers scalability with ability to ramp resources up or down while maintaining oversight.
  2. Project-Based Services: Ephicacy takes full ownership of defined deliverables and timelines with dedicated teams for data managers, programmers, and statisticians. Milestone-based support with budget predictability.
  3. Clinical Development Consulting: Expert guidance at early planning stages including study design, regulatory interactions, and statistical modeling. Flexible hours and resource-on-demand model.
  4. Hybrid Models: Blending FSP and project-based models to provide support exactly where and how clients need it, accommodating multiple projects with varying support needs.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractFSP Model - Ongoing embedded support with scalable resources
Outcome Based/ PerformanceMulti-year contractProject-Based Model - Milestone-based delivery with defined deliverables
OtherPay-as-you-goConsulting Model - Expert guidance on demand

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

Ephicacy product offering

Product offering

Core offering

Ephicacy is a niche Contract Research Organization (CRO) providing consulting and operational services in statistical programming, SDTM, ADaM, and clinical data management across all phases of clinical trials. It delivers biometrics, biostatistics, CDISC compliance, real-world evidence, pharmacovigilance, and AI-enabled clinical data operations to pharmaceutical, biotech, and medical device sponsors through FSP, project-based, and consulting engagement models.

Product overview

Ephicacy is a biometrics Contract Research Organization (CRO) offering a comprehensive suite of clinical data analytics services organized around three partnership models: Functional Service Provider (FSP), Project-Based Services, and Consulting. The core service portfolio includes Data Management (with sub-services Clinical Programming and Data Integration & Visualization), Biostatistics (with DMC Services), Statistical Programming (with CDISC Standards & Governance and R Programming sub-services), AI for Clinical Data Operations, Real-World Evidence & Observational Study Analytics, Pharmacovigilance (with Clinical Literature Review), Project Management, and Medical Device biometrics support. This is a services-based offering rather than a packaged software product, delivered through a global team across North America, India, and Europe with 24/7 coverage capabilities.

Differentiator

Problem solved

Functional benefit

Products and services

  • Data Management Comprehensive clinical trial data management services combining capacity and expertise through a global team with 24/7 coverage, including CRF design, EDC implementation, database design, data cleaning, query management, and medical coding. Includes Clinical Programming and Data Integration & Visualization sub-capabilities such as edit check reports, patient profiles, narratives, and lab reconciliation reports across EDC, labs, imaging, Spotfire, Tableau, Qlik, R Shiny, AWS, and Databricks platforms. Intended for pharmaceutical, biotech, and medical device sponsors running clinical trials.
  • Biostatistics Real-world and clinical biostatistics services including statistical design, conduct, monitoring, and reporting, plus protocol input, sample size calculations, SAP development, Tables/Listings/Figures (TLFs), CSR development, publications, and Data Monitoring Committee (DMC) support. Includes dedicated DMC services with unblinded output generation across oncology, neuroscience, cardiovascular, and other therapeutic areas. Intended for pharmaceutical and biotech sponsors.
  • Statistical Programming End-to-end statistical programming support including CDISC-compliant SDTM and ADaM dataset programming, TLF production, submission-ready SAS and R programming, ISS/ISE programming, and eSUB package preparation for regulatory submissions. Includes CDISC Standards & Governance (CDASH/SDTM/ADaM mapping, Pinnacle21 validation, eCTD submission packages, define.xml generation) and R Programming (R Shiny dashboards, custom packages, SAS-to-R migration, validated production environments). Programmers average 5+ years of CDISC experience. Intended for clinical trial sponsors requiring regulatory submission-ready datasets.
  • AI for Clinical Data Operations AI adoption strategy and tools for clinical data operations including TLF (Tables, Listings, Figures) automation, CSR drafting accelerators, SAS-to-R code migration assistance, data review assistant for anomaly surfacing, clinical literature review copilots, and protocol-to-SAP mappers. Includes governance and validation playbooks and AI training programs. Teams adopting these tools have realized cost reductions up to 30% and target less than 1% error rates in automated steps under defined controls. Intended for clinical development teams seeking efficiency gains in regulated biometrics workflows.
  • Real-World Evidence & Observational Study Analytics Real-world evidence analytics services including evidence strategy, data source acquisition from claims/EHR/pharmacy/registries/labs/PRO, data standardization to OMOP, HL7 FHIR, and CDISC, comparative effectiveness analysis, external control arms, treatment pattern analytics, and visualization for submissions. Source-agnostic data strategy intended for pharmaceutical and biotech sponsors pursuing regulatory submissions with real-world data.
  • Pharmacovigilance Pharmacovigilance services for detecting, analyzing, and reporting safety signals including safety data analytics, clinical literature review with weekly multilingual monitoring and AI-enabled screening (37,900+ articles screened), signal detection, and regulatory document support (Investigator Brochure, Risk Management Plan, PBRER), plus gap analysis. Intended for pharmaceutical sponsors requiring ongoing drug safety monitoring.
  • Project Management Strategic project management for clinical data operations delivered as a consulting service or as part of FSP and project-based delivery models, providing coordination across technical, operational, and financial dimensions. Intended for clinical trial sponsors requiring outsourced program leadership.
  • Medical Device Biometrics Specialized biometrics support for medical device, diagnostic, and combination-product trials including clinical trial design, IDE strategy, clinical event adjudication, DMC support, database design for dense data capture, complex randomization, and FDA engagement support. Includes 300+ device programs supported and 100+ successful regulatory submissions for medical device programs. Intended for medical device and diagnostic companies.
  • Functional Service Provider (FSP) Partnership Model Flexible FSP engagement model offering dedicated functional expertise, scalable resourcing, sponsor-aligned delivery under sponsor processes, SOPs, and systems, and continuity for long-term partnership. Ring-fenced resources embedded within sponsor teams with ability to ramp up or down. Multi-year contract pricing. Intended for enterprise pharma sponsors with ongoing biometrics resourcing needs.
  • Project-Based Services Partnership Model Project-based service model with end-to-end delivery ownership where Ephicacy takes full accountability for defined deliverables, timelines, and outcomes with milestone-based support and established budgets. Rapid onboarding and hands-on custom solutions. Multi-year contract pricing. Intended for midsize pharma, biotech, and medical device sponsors with project-scoped biometrics needs.
  • Clinical Development Consulting Clinical development consulting providing early-stage strategic guidance including study design optimization, regulatory authority interaction guidance, statistical modeling, standardized data flows, and CDISC compliance implementation. Flexible hours and resource-on-demand model with pay-as-you-go billing. Intended for emerging biotech and small pharma with limited internal biometrics resources.

Quantifiable outcome

  • 94% team retention rate ensuring client programs work with experienced professionals who know their programs
  • +5 more outcomes

Companies that use Ephicacy

Customer profile

Named customers7 records

Segments4 records

Ideal customer profiles4 records

Ephicacy technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability12 records

Feature5 records

Ephicacy partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Advance Research AssociatesmajorOthers · 2 May 2024Ephicacy Consulting Group completed the acquisition of Advance Research Associates in May 2024, expanding its biometrics and analytics capabilities.

Scale indicators12 records

Recent moves6 records

Expansion highlights6 records

Ephicacy competitors and assessment

Company assessment

Broad incumbents

  • Fortrea (formerly LabCorp Drug Development): Fortrea is a global CRO spun out of LabCorp in 2023 offering clinical and biometrics services. Broad incumbent with biometrics overlap; competes against Ephicacy on FSP and biometrics outsourcing bids.
  • IQVIA: IQVIA is the largest global full-service CRO with deep biometrics and RWE capabilities through its Quintiles heritage. Ephicacy's Jamie Powers previously worked at IQVIA. Broader incumbent offering overlapping biometrics but as part of a much wider portfolio.
  • Parexel International: Parexel is a major global full-service CRO with biometrics and biostatistics capabilities. Broad incumbent overlapping with Ephicacy in CDISC, statistical programming and biostatistics but as part of an end-to-end clinical offering.
  • ICON plc: ICON plc is a top-tier global CRO with full clinical and biometrics services following the PRA Health Sciences merger. Broad incumbent competing with Ephicacy on biometrics within larger full-service deals, especially with large pharma.

Direct peers

  • Cytel: Cytel is a specialty biometrics CRO with deep biostatistics and statistical programming capabilities serving global pharma and biotech. Directly comparable in services (statistical programming, CDISC, biostatistics) and therapeutic-area focus, with overlapping FSP and consulting delivery models.
  • Phastar: Phastar is a specialist biometrics CRO offering data management, biostatistics, statistical programming and CDISC services to pharma and biotech globally. Direct peer in niche biometrics with global delivery model and similar mid-market positioning to Ephicacy.
  • Veramed: Veramed is a biometrics CRO specializing in biostatistics and statistical programming for pharma and biotech. Direct comparable with similar service portfolio, mid-tier customer mix, and biostatistics/statistical programming as primary offerings.
  • Rho: Rho is a US-based biometrics-focused CRO offering data management, biostatistics, statistical programming and regulatory services to pharma and biotech. Highly comparable: Ephicacy's new CEO Tara Gladwell came directly from Rho as President, and the two firms compete head-to-head in mid-market biometrics outsourcing.

Emerging players

  • Precision for Medicine: Precision for Medicine is a CRO specializing in biomarker-driven and precision medicine trials, with biometrics and biostatistics capabilities. Emerging peer with strong overlap in specialty/biomarker-enabled clinical analytics and RWE work relevant to Ephicacy's RWE and specialty therapeutic services.
  • Clario: Clario is a clinical trial technology and endpoint services company with biometrics integration and eCOA/ePRO strengths. Partially overlapping with Ephicacy's data management and clinical data integration services, particularly around EDC, clinical data review and AI-enabled workflows.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Ephicacy social profiles

Digital presence

Ephicacy compliance and trust

Trust signal

Compliance3 records

Ephicacy financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Ephicacy leadership team

Management profile

Number of profiles

Profiles12 records

Ephicacy subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Ephicacy funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Ephicacy M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ephicacy

What does Ephicacy do?

Ephicacy is a niche Contract Research Organization (CRO) providing consulting and operational services in statistical programming, SDTM, ADaM, and clinical data management across all phases of clinical trials. It delivers biometrics, biostatistics, CDISC compliance, real-world evidence, pharmacovigilance, and AI-enabled clinical data operations to pharmaceutical, biotech, and medical device sponsors through FSP, project-based, and consulting engagement models.

Is Ephicacy a public or private company?

Ephicacy is a private company. It is classified as private equity controlled and is currently operating.

When was Ephicacy founded?

Ephicacy was founded in 2005. It employs 251 to 500 people.

Where is Ephicacy based?

Ephicacy is headquartered in Iselin, United States, in the North America region.

How does Ephicacy make money?

Four revenue lines are on record. Functional Service Provider (FSP) Model is the primary driver. The others are project-Based Services, clinical Development Consulting and hybrid Models.

Who are Ephicacy's main competitors?

Broad incumbents on record are Fortrea (formerly LabCorp Drug Development), IQVIA, Parexel International and ICON plc. Direct peers are Cytel, Phastar, Veramed and Rho. Emerging players are Precision for Medicine and Clario.

Does Ephicacy have an API?

No public API is recorded for Ephicacy.

What industry is Ephicacy in?

Ephicacy's product category is Clinical Biometrics Contract Research Organization (CRO). Its primary akta.pro industry code is HLAGAAAF, Clinical Data Management, Biostatistics & Statistical Programming CROs, with a secondary code of HLAGAOAB, Data Management, Biostatistics & Statistical Programming FSP. Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business Wire BlogEphicacy Appoints Dr. Shekhar Thumake as Head of AI to Advance AI-Enabled Clinical Data OperationsEphicacy appointed Dr. Shekhar Thumake as head of AI, a newly created role to advance AI-enabled clinical data operations. He will lead enterprise AI strategy and agentic AI capabilities, embedding interoperability and regulatory considerations. The appointment supports Ephicacy's strategy to embed AI across the clinical data life cycle.citybizQ&A with Jamie Powers, Ephicacy’s SVP of BiometricsEphicacy, a global biometrics CRO, has appointed Jamie Powers as Senior Vice President of Biometrics, with Powers stating his immediate priority is to spend his first weeks listening to and understanding the organization's existing capabilities, client relationships, and delivery model. Industry data shows 28 out of 31 pharmaceutical and biotech companies reported increasing R utilization in 2025, with organizational change management identified as the primary barrier to adoption rather than technical limitations. Powers emphasized that AI should be treated as an efficiency tool that augments rather than replaces human expertise in regulated biometrics, while noting India's critical role as a delivery hub for the company's global operations.PharmiWeb.comEphicacy Appoints Jamie Powers as SVP of Biometrics and Names Tyagi Swaminathan Head of India OperationsEphicacy, a biometrics contract research organization headquartered in Iselin, New Jersey, announced the appointment of Jamie Powers as Senior Vice President of Biometrics and Tyagrajan "Tyagi" Swaminathan as Head of India Operations and Vice President of Statistical Programming. Powers will lead the company's Project-Based Services unit, encompassing Data Management, Biostatistics, and Statistical Programming, and brings over 23 years of experience from organizations including IQVIA, SAS Institute, ConcertAI, and Takeda Pharmaceutical. The appointments underscore Ephicacy's continued investment in scaling its biometrics and analytics capabilities to meet growing demand for advanced statistical programming in clinical development.EphicacyClinical Data Management Case StudyEphicacy presented a case study detailing its provision of clinical data management services to pharmaceutical clients through an FSP model and resource recruitment. The article highlights specific operational successes, including the establishment of in-house teams, validation of EDC platforms, and mitigation of staffing shortages for emerging pharma companies.EphicacyEphicacy Consulting GroupEphicacy Consulting Group provides Real World Evidence (RWE) analytics services to connect Randomized Controlled Trial (RCT) data with Real World Data (RWD) to help clients demonstrate the value and effectiveness of treatments in real-world settings. The firm addresses challenges in data analysis and impact measurement for RWE while ensuring data protection and security, leveraging its expertise with patient data. RWE is seen as promising due to its potential to improve health outcomes and cost-effectiveness of new treatments.BioXconomyEphicacy buys ARA to add biostats and data management capabilitiesEphicacy has acquired ARA to enhance its biostatistics and data management capabilities, with ARA's CEO Peter Shabe joining Ephicacy as global head of biostatistics consulting. The acquisition aims to address growing market demand for informatics technologies in clinical trials, building on ARA's history of supporting over 700 clinical trials. This move follows recent executive hires and investment from Great Point Partners, signaling Ephicacy's continued expansion strategy.Business Wire BlogEphicacy Appoints Névine Zariffa to Its Board of DirectorsEphicacy Consulting Group appointed Névine Zariffa to its board of directors. Zariffa brings over 25 years of biostatistics and data science experience, including senior roles at GlaxoSmithKline and AstraZeneca, and has contributed to over 200 drug development programs.YahooEphicacy Appoints Névine Zariffa to Its Board of DirectorsEphicacy Consulting Group, Inc. announced the appointment of Névine Zariffa to its Board of Directors. Névine Zariffa is a biostatistics and data science expert with over 25 years of experience, including leadership roles at GlaxoSmithKline and AstraZeneca.PrwebGreat Point Partners Completes Investment in Ephicacy Consulting Group to Fund Accelerated GrowthGreat Point Partners completed a growth investment in Ephicacy Consulting Group to fund its accelerated expansion. The transaction supports the biometrics Contract Research Organization, which provides statistical programming and analytics services for pharmaceutical companies across the United States, Canada, and India.GppfundsGreat Point Partners Completes Investment in Ephicacy Consulting Group to Fund Accelerated GrowthGreat Point Partners has completed a growth investment in Ephicacy Consulting Group to fund its accelerated expansion. Ephicacy is a biometrics Contract Research Organization providing statistical programming and data management services to pharmaceutical and biotechnology clients across the United States, Canada, and India.